US Patent 7691603 Intracellular formation of peptide conjugates
Patent 7691603 was granted and assigned to Novo Nordisk on April, 2010 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
April 9, 2004
Date of Patent
April 6, 2010
Patent Application Number
10549528
Patent Citations Received
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 7691603 Intracellular formation of peptide conjugates
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.